HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: Possibility of coinfection in these patients must be considered in HBV-high endemic area

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 12, 1997, Pages 855-861

  Lee, Dong Soon ^a   Huh, Kwang ^a   Lee, Enu Hee ^b   Lee, Dong Ho ^c   Hong, Ki Sook ^d   Sung, Young Chul ^e  

^a Korea Cancer Center Hospital   (South Korea)

^b Green Cross Company   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Ewha Womans University   (South Korea)

^e Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Coinfection; HBV; HCV; Hepatocellular carcinoma; Interference

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPERINFECTION; VIREMIA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS PATHOGENESIS;

EID: 0031431329     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00383.x     Document Type: Article

References (23)

1. NSO: National Statistical Office. 1993 Annual report on the cause of death statistics, vol. 14. Seoul: NSO, 1994.
2. Shiratori Y, Shina S, Imamura M et al. Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan. Hepatology 1995; 22: 1027-33.
3. Okuda K. Hepatocellular carcinomas associated with hepatitis B and C virus infection: Are they any different? Hepatalogy 1995; 22: 1883-5.
4. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 1993; 67: 5823-32.
5. Shih CM, Chen CM, Chen SY, Lee YH. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 1995; 69: 1160-71.
6. Brotman B, Prince AM, Huima T, Richardson L, van den Ende MC, Pfeifer U. Interference between non-A, non-B and hepatitis B virus infection in chimpanzees. J. Med. Virol. 1983 11: 191-205.
7. Tsiquaye KN, Portmann B, Tovey G, Kessler H, Hu S, Lu XZ. Non-A, non-B hepatitis in persistent carriers of hepatitis B virus. J. Med. Virol. 1983; 11: 179-89.
8. Hollinger FB, Dolana G, Thomas W, Gyorkey F. Reduction in risk of hepatitis transmission by heat a human factor VIII concentrate. J. Infect. Dis. 1984; 150: 250-62.
9. Okamoto H, Okada S, Suguyama Y et al. 5′ terminal sequence of the hepatitis C virus genome. Jpn. J. Exp. Med. 1990; 60: 167-77.
10. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C virus by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 1993; 31: 882-6.
11. Shin HR, Lee CU, Ahn YO. Case-control studies on hepatocellular carcinoma among Koreans in Seoul and Pusan. In: Kim CY and Shigematsu T, eds. Comparative Features of Liver Cancer between Korea and Japan, Epidemiology, Pathology, and Etiology, Proceedings of the Korea-Japan Liver Cancer Symposium. Seoul: 1992; 36-44.
12. Kaklamani E, Trichopoulos D, Tzonou A et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991; 265: 1974-6.
13. Chung WL, Chang WT, Lu SN et al. The role of hepatitis C virus in chronic hepatitis B virus infection. Gastroenterologyca Japonica 1993; 28: 23-7.
14. Tsai JF, Jeng JE, Ho MS, Chang WY, Un ZY, Tsai JH. Hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Chinese: A case control study. Int. J. Cancer 1994; 56: 619-21.
15. Paterlini P, Driss F, Nalpas B et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 1993; 17: 20-9.
16. Sardo MA, Rodino G, Brancatelli S et al. Inapparent 'wild type' and ge-minus variation HBV infection in patients with HCV related chronic hepatitis. Liver 1994; 14: 241-4.
17. Dienstag JL, Isselbacher KJ, eds. Principles of Internal Medicine, 14th edn. New York: McGraw-Hill, 1995; 1458-77.
18. Ito S, Yao DF, Nu C et al. Incidence of hepatitis C virus (HCV) antibodies and HCV-RNA in blood donors and patients with liver diseases in the inshore area of the Yangtze river. J. Gastroenterol. Hepatol. 1994; 9: 245-9.
19. Goeser T, Muller HM, Solbach C et al. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma. Cancer Epidemiol. Biomarkers. Prev. 1994; 3: 311-15.
20. Ruiz J, Sangro B, Cuede JI et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992; 16: 637-41.
21. Bukh J, Miller RH, Kew MC, Purcell RH. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 1993; 90: 1848-51.
22. Darwish MA, Issa SA, Aziz AM, Darwish NM, Soliman AH. Hepatitis C and B viruses, and their association with hepatocellular carcinoma in Egypt. J. Egypt Public Health Assoc. 1993; 68: 1-9.
23. Resnick RH, Koff R. Hepatitis C-related hepatocellular carcinoma, prevalence and significance. Arch. Intern. Med. 1993; 153: 1672-7.